Statistical analysis of the symptoms contributing to the diagnosis of malaria: a case study of federal medical Centre Ilara, Ogun state, Nigeria

  • Authors

    • Abdullahi H University of Ilorin, Nigeria
    • Oyeyemi G.M Department of Statistics, University of Ilorin, Ilorin, Nigeria
    • Kareem A . O National Institute for Security Studies, Bwari, Abuja
    2024-12-26
    https://doi.org/10.14419/spawa134
  • Diagnosis; Logistic regression; Malaria parasite; Odd ratio; Symptoms JEL Classification: C15.

  • Abstract

    Malaria in humans is an acute or sub-acute infectious disease caused by one of six protozoan species of the genus Plasmodium: P. falciparum, P. vivax, P. ovale wallikeri, P. ovale curtisi, P. malariae and P. knowlesi, transmitted by Anopheles mosquitoes. Malaria remains one of the most serious global health problems with the World Health Organization (WHO) reporting hundreds of millions of cases and hundreds of thousands of deaths annually, predominantly in sub-Saharan Africa. The study aimed at carrying out statistical analysis on patients who presented themselves to the physician on their claim of having malaria, a case study of Federal Polytechnic Ilaro Medical Centre, Ogun state, Nigeria. The participants were 337 patients of which 180 are Female and 157 are Male within the age range of 3-77 years of age. The statistical analysis of symptoms contributing to the diagnosis of malaria highlighted several key findings. Logistic regression was used for the basic analysis of the dataset and it was discovered that people in the age range 38–47 years are mostly affected with malaria and that females are the most infected gender species with headache being the most significant symptom based on its Wald statistic value.

  • References

    1. Bloland, P. B. (2001). Drug resistance in malaria. World Health Organization. Retrieved from https://apps.who.int/iris/handle/10665/66847.
    2. Breman, J. G., Alilio, M. S., & Mills, A. (2004). Conquering the intolerable burden of malaria: what's new, what's needed: a summary? American Journal of Tropical Medicine and Hygiene, 71(2_suppl), 1-15. https://doi.org/10.4269/ajtmh.2004.71.2_suppl.0700001.
    3. Caraballo, H. (2014). Emergency department management of mosquito-borne illness: Malaria, dengue, and West Nile virus. Emergency Medicine Practice, 16(5), 1-23.
    4. Carter, R., & Mendis, K. N. (2002). Evolutionary and historical aspects of the burden of malaria. Clinical Microbiology Reviews, 15(4), 564-594. https://doi.org/10.1128/CMR.15.4.564-594.2002.
    5. Centers for Disease Control and Prevention, CDC, (2014). Malaria. Retrieved from https://www.cdc.gov/malaria/index.html.
    6. Centers for Disease Control and Prevention, CDC, (2020). Anopheles Mosqui-toes.https://www.cdc.gov/malaria/about/biology/mosquitoes/index.html.
    7. Centers for Disease Control and Prevention, CDC, (2022). Malaria. Retrieved from https://www.cdc.gov/malaria/index.html
    8. Collins, W. E., & Jeffery, G. M. (2005). Plasmodium malariae: parasite and disease. Clinical Microbiology Reviews, 18(4), 708-734. https://doi.org/10.1128/CMR.18.3.570-581.2005.
    9. Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., & White, N. J. 2010). Artemisinin resistance in Plasmodium falci-parum malaria. New England Journal of Medicine, 361(5), 455-467. https://doi.org/10.1056/NEJMoa0808859.
    10. Gomes, A. P., Vitor-Silva, S., Lacerda, M. V. G., Alecrim, M. G., Alecrim, W. D., & Lacerda, M. V. G. (2002). Acute renal failure in severe malaria: risk factors, pathophysiology, and prognosis. Revista do Instituto de Medicina Tropical de São Paulo, 44(6), 341 - 347.
    11. Imbert, P., Gerardin, P., Rogier, C., Ka, A. S., Jouvencel, P., Brousse, V & Deloron, P. (1997). Severe malaria among children in a low seasonal transmission area, Dakar, Senegal: influence of age on clinical presentation. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91(1), 22-24. https://doi.org/10.1016/S0035-9203(97)90380-1.
    12. Lengeler, C. (2004). Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database of Systematic Reviews, 2. CD000363. https://doi.org/10.1002/14651858.CD000363.pub2.
    13. Nigeria Malaria Indicator Survey. (2015). Malaria Indicator Survey 2015: Key Indicators. National Malaria Elimination Programme (NMEP).
    14. Oladimeji, K. E., Tsoka-Gwegweni, J. M., Mchunu, G. G., & Kahiga, T. M. (2019). Regional and socio-economic differences in knowledge, attitudes and practices relating to malaria in Nigeria: A cross-sectional study. African Journal of Primary Health Care & Family Medicine, 11(1), 1-8.
    15. Snow, R. W., Marsh, K., & Le Sueur, D. (1998). The need for maps of transmission intensity to guide malaria control in Africa. Para-sitology Today, 14(6), 191-194.
    16. Sullivan, D. J., Gluzman, I. Y., Russell, D. G., & Goldberg, D. E. (1999). On the molecular mechanism of chloroquine's antimalarial action. Proceedings of the National Academy of Sciences, 93(21), 11865-11870. https://doi.org/10.1073/pnas.93.21.11865.
    17. Tan, K. S., Lee, H. Y., & Yap, E. P. H. (2011). Clinical and biological evidence for a potential role of L-arginine in the pathogenesis of severe malaria. Trends in Parasitology, 27(4), 159-166.
    18. Trampuz, A., Jereb, M., Muzlovic, I., & Prabhu, R. M. (2003). Clinical review: Severe malaria. Critical Care, 7(4), 315-323. https://doi.org/10.1186/cc2183.
    19. Wells, R. E. (2009). Platelets in cerebral malaria: a role for von Willebrand factor. Journal of Clinical Investigation, 119(4), 833-835.
    20. White, N. J. (2018). Anaemia and malaria. Malaria Journal, 17(1), 371. https://doi.org/10.1186/s12936-018-2509-9.
    21. White, N. J., Pukrittayakamee, S., Hien, T. T., Faiz, M. A., Mokuolu, O. A., & Dondorp, A. M. (2014). Malaria. Lancet, 383(9918), 723-735. https://doi.org/10.1016/S0140-6736(13)60024-0.
    22. World Health Organization, WHO, (2014). World Malaria Report 2014. Retrieved from https://www.who.int/publications/i/item/9789241564830
    23. World Health Organization, WHO, (2015). Global technical strategy for malaria 2016-2030. https://www.who.int/publications/i/item/9789241564991
    24. World Health Organization (WHO). (2000). Severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hy-giene, 94(suppl_1), S1-S90. https://doi.org/10.1016/S0035-9203(00)90300-6.
    25. World Health Organization, WHO, (2021). World Malaria Report 2021. Geneva: World Health Organization. https://doi.org/10.30875/6c551ba0-en.
    26. World Health Organization, WHO, (2023). World Malaria Report 2023. Retrieved from https://www.who.int/publications/i/item/9789240077185.

  • Downloads